The cytopathological spectrum of lymphomas in effusions in a tertiary center in Taiwan
- PMID: 32975910
- DOI: 10.1002/dc.24626
The cytopathological spectrum of lymphomas in effusions in a tertiary center in Taiwan
Abstract
Lymphomas presenting in effusions could either be primary or secondary, with very limited data from Taiwan.
Methods: We retrospectively reviewed effusion lymphomas from our archives in a tertiary center from July 2011 to June 2019.
Results: We identified 59 specimens from 43 patients, including 7 cases with primary effusion lymphoma (PEL) and 36, secondary effusion involvement. Half of the secondary cases presented concurrently with effusion lymphoma, while the remaining half-experienced effusion lymphoma during disease progression. All patients with PELs were males with a median age of 77 and presented with massive pleural effusion. None was HIV-related. Two (29%) PEL cases were positive for human herpes virus 8 (HHV8). The only case with plasmablastic phenotype in the PEL group was positive for both HHV8 and EBV. Four patients died shortly after diagnosis; while the remaining three were alive at the last follow-up (two at 13 months and one at 99 months). Of the secondary cases, diffuse large B-cell lymphoma/high grade B-cell lymphoma was the most common (n = 16, 44%), followed by mantle cell lymphoma (n = 5, 14%). Only 8 cases (22%) were T-cell neoplasms. Prognosis for patients with secondary effusion involvement was dismal, with 1- and 2-year overall survival rates at 17% and 8%, respectively.
Conclusion: We found a wide cytopathological spectrum of effusion lymphoma in Taiwan. Most of our PEL cases were distinct from that defined in the World Health Organization scheme by a B-cell phenotype, HHV8-negativity, and absence of immunodeficiency. As compared to PEL cases, the prognosis of those with secondary involvement was extremely poor.
Keywords: body fluid; cytology; effusion lymphoma; herpes simplex virus type 8; primary effusion lymphoma.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Bintcliffe OJ, Hooper CE, Rider IJ, et al. Unilateral pleural effusions with more than one apparent etiology. A prospective observational study. Ann Am Thorac Soc. 2016;13(7):1050-1056.
-
- Patel T, Patel P, Mehta S, Shah M, Jetly D, Khanna N. The value of cytology in diagnosis of serous effusions in malignant lymphomas: An experience of a tertiary care center. Diagn Cytopathol. 2019;47(8):776-782.
-
- Said JW, Cesarman E. Primary effusion lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haemtopoietic and Lymphoid Tissues. Lyon: IARC; 2017:323-324.
-
- Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443-459.
-
- Taghizadeh N, Fortin M, Tremblay AUS. hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest. 2017;151(4):845-854.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
